Semax

Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) originally derived from adrenocorticotropic hormone (ACTH 4-10). It has been studied in vitro for its potential neuroprotective, nootropic, and neurorestorative properties. Research suggests Semax may influence the expression of brain-derived neurotrophic factor (BDNF), support synaptic plasticity, and modulate the central nervous system’s adaptive responses to stress and injury. Provided in a 10mg lyophilized format, Semax is ideal for controlled research settings focused on neurological and cognitive studies.